Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Allen Gabriel

Plastic Surgery Vancouver, WA Medical Doctor

NPI 1821146770 CMS profile 37741

703 Broadway St Ste 700, Vancouver, WA 98660

Open in the dashboard

General payments

$872,860

766 records reported · program years 2019–2025

Research payments

$27,064

Paid to them · 15 records reported · program years 2019–2025

Ownership & investment interest

$198,550

5 holdings reported · through program year 2025

Research they led as principal investigator

$283,926 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Allen Gabriel of Vancouver, WA is reported in the CMS Open Payments database as having received $872,860 across 766 general payments and $27,064 in research payments paid to them. Separately, studies naming them as principal investigator received $283,926 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $198,550 across 5 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

15 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $145,885 122
2025 Research $2,764 8
2024 General $129,706 127
2024 Research $3,500 6
2023 General $119,748 138
2022 General $86,921 96
2021 General $94,125 104
2021 Research $20,800 1
2020 General $97,556 47
2019 General $198,919 132
2025 Ownership $30,900 1
2024 Ownership $30,900 1
2023 Ownership $30,900 1
2022 Ownership $30,900 1
2021 Ownership $74,952 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Allen Gabriel
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Allen Gabriel were reported at $145,885. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Allen Gabriel Plastic Surgery median Middle half National median
2019 $198,919 $371 $122–$1,483 $163
2020 $97,556 $158 $52–$438 $114
2021 $94,125 $249 $87–$752 $132
2022 $86,921 $274 $102–$793 $149
2023 $119,748 $299 $113–$891 $160
2024 $129,706 $361 $124–$1,062 $164
2025 $145,885 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $382,159 337 payments
  2. Allergan Inc. $326,069 305 payments
  3. KCI USA, Inc $154,017 61 payments
  4. Solventum Corporation $6,070 3 payments
  5. Integra LifeSciences Corporation $1,465 14 payments
  6. Merz North America, Inc. $1,241 6 payments
  7. Motiva USA, LLC $795 8 payments
  8. Davol Inc. $511 11 payments
  9. Galderma Laboratories, L.P. $116 6 payments
  10. TELA Bio, Inc. $90 3 payments
  11. Other $328 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $409,868 128 payments
  2. Consulting Fee $357,200 112 payments
  3. Travel and Lodging $68,854 142 payments
  4. Food and Beverage $17,169 376 payments
  5. Gift $16,287 5 payments
  6. Education $2,505 2 payments
  7. Long term medical supply or device loan $977 1 payment
Products named General payments · program years 2019–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $318,385 254 payments
  2. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $163,912 131 payments
  3. REVOLVE $163,414 126 payments
  4. ALLODERM $83,313 66 payments
  5. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $53,591 23 payments
  6. NATRELLE $47,479 54 payments
  7. VAC VERAFLO $33,745 9 payments
  8. PREVENA Non-Covered $32,487 16 payments
  9. STRATTICE $29,725 27 payments
  10. PREVENA Negative Pressure Systems & Dressings $20,162 11 payments
  11. Other $100,708 185 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Allergan Inc. $20,800 1 payment
  2. Motiva USA, LLC $5,000 10 payments
  3. AbbVie, Inc. $1,006 3 payments
  4. Davol Inc. $258 1 payment

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$7,038

Medicare's payments for the services billed

Medicare patients

30

Average age 72

Services billed

51

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Cancer 75%
High blood pressure 57%
Arthritis 47%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
  • AbbVie, Inc. $26
$26 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

781 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record